CDSCO Panel Flags Small Sample Size, Limited Scope, Asks Zydus to Rework Phase IV Letermovir Study
- 18 October 2025
- 2 weeks ago
CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin Study
- 17 October 2025
- 2 weeks ago
CDSCO Panel Seeks More Clinical Data from Regenix Drugs on rDNA-Based Insulin Injection
- 16 October 2025
- 2 weeks ago
CDSCO Panel Clears BDR Pharma's Abiraterone Oral Suspension, Seeks Phase IV Trial
- 15 October 2025
- 2 weeks ago
Reliance Life Sciences Gets CDSCO Panel Nod for Phase I/III Trial of Biosimilar Nivolumab
- 14 October 2025
- 2 weeks ago
Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet
- 14 October 2025
- 2 weeks ago
ED Raids Sresan Pharma
- 13 October 2025
- 2 weeks ago
30 Pharma Firms Under MPFDA, CDSCO Scanner in Madhya Pradesh
- 13 October 2025
- 2 weeks ago
Indore pharma unit under fire as inspection flags 216 lapses
- 13 October 2025
- 2 weeks ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









